IRCCS San Raffaele Scientific Institute

Milan 20132

1 studies enrolling now · 5 studies all time

What they study most

Arterial Thrombosis, Cardiogenic Shock, Myocardial Injury After Noncardiac Surgery (MINS), Perioperative Bleeding, Refractory Hematologic Malignancy, Refractory Primary Central Nervous System Lymphoma, Relapsed Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Venous Thrombosis

Studies at this site

• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Running, not enrolling
• PeriOperative ISchemic Evaluation-3 Trial — Completed
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock — Completed
• Management of Myocardial Injury After Noncardiac Surgery Trial — Completed